This inventor holds 1 USPTO granted patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Marjanca Blas: Innovator in Recombinant Protein Expression
Introduction
Marjanca Blas is a notable inventor based in Auburn Hills, MI (US). She has made significant contributions to the field of recombinant protein expression. Her innovative work focuses on improving the efficiency of cell line development.
Latest Patents
Marjanca holds a patent titled "Predicting productivity in early cell line development." This invention relates to a method for selecting suitable candidate cell clones for recombinant protein expression. The host cell in her invention exhibits artificially modified gene expression of specific genes, enhancing the overall productivity of protein expression.
Career Highlights
Marjanca is currently associated with Lek Pharmaceuticals D.d., where she applies her expertise in biotechnology. Her work has been instrumental in advancing the methodologies used in recombinant protein production.
Collaborations
Marjanca collaborates with talented professionals such as Uros Jamnikar and Kristina Gruden. Together, they contribute to innovative projects that push the boundaries of biotechnology.
Conclusion
Marjanca Blas is a pioneering inventor whose work in recombinant protein expression is shaping the future of biotechnology. Her contributions are vital for advancements in the field, and her patent reflects her commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile